Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments.


Journal

Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521

Informations de publication

Date de publication:
28 Oct 2019
Historique:
received: 27 06 2019
accepted: 30 09 2019
entrez: 30 10 2019
pubmed: 30 10 2019
medline: 4 12 2019
Statut: epublish

Résumé

Caco-2 monolayers are the most common model of the intestinal epithelium and are critical to the development of oral drug delivery strategies and gastrointestinal disease treatments. However, current monolayer systems are cost- and/or time-intensive, hampering progress. This study evaluates two separate methods to reduce resource input: FB Essence as a fetal bovine serum (FBS) alternative and a new, 3-day Caco-2 system deemed "thrifty, rapid intestinal monolayers" (TRIM). Caco-2 cells were cultured with FB Essence and compared to cells in 10% FBS for proliferation and monolayer formation. TRIM were compared to commonly-used 21-day and Corning® HTS monolayer systems, as well as mouse intestines, for permeability behavior, epithelial gene expression, and tight junction arrangement. No amount of FB Essence maintained Caco-2 cells beyond 10 passages. In contrast, TRIM compared favorably in permeability and gene expression to intestinal tissues. Furthermore, TRIM cost $109 and required 1.3 h of time per 24-well plate, compared to $164 and 3.7 h for 21-day monolayers, and $340 plus 1.0 h for the HTS system. TRIM offer a new approach to generating Caco-2 monolayers that resemble the intestinal epithelium. They are anticipated to accelerate the pace of in vitro intestinal experiments while easing financial burden.

Identifiants

pubmed: 31659456
doi: 10.1007/s11095-019-2712-6
pii: 10.1007/s11095-019-2712-6
doi:

Substances chimiques

Dextrans 0
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

172

Références

Pharm Res. 2008 Jun;25(6):1412-9
pubmed: 18311478
J Pharm Sci. 2008 Feb;97(2):712-25
pubmed: 17542022
Nat Protoc. 2010 May;5(5):929-34
pubmed: 20431538
Toxicol In Vitro. 2012 Dec;26(8):1243-6
pubmed: 22465559
Annu Rev Physiol. 2011;73:283-309
pubmed: 20936941
J Pharm Sci. 2002 Mar;91(3):669-79
pubmed: 11920752
Biochem J. 1992 Jun 1;284 ( Pt 2):595-601
pubmed: 1318037
Nanomedicine. 2015 Jul;11(5):1117-32
pubmed: 25784453
Pharm Res. 2017 Jun;34(6):1320-1329
pubmed: 28374339
Pharm Res. 1997 Dec;14(12):1835-7
pubmed: 9453077
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43
pubmed: 11259831
Lab Anim. 2010 Jul;44(3):176-83
pubmed: 20007641
Mol Pharm. 2016 Feb 1;13(2):578-85
pubmed: 26730955
Cytotechnology. 2013 Oct;65(5):791-3
pubmed: 23975256
Food Chem. 2013 Nov 1;141(1):29-33
pubmed: 23768322
Toxicol In Vitro. 2012 Dec;26(8):1247-51
pubmed: 22123491
Cell Biol Toxicol. 2005 Jan;21(1):1-26
pubmed: 15868485
J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):176-83
pubmed: 16891127
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):395-411
pubmed: 18433344
Nano Lett. 2013 Jan 9;13(1):164-71
pubmed: 23186530
Int J Pharm. 2000 Apr 25;200(1):41-51
pubmed: 10845684
Drug Dev Ind Pharm. 2013 Apr;39(4):587-92
pubmed: 22656319
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):277-319
pubmed: 27320643
J Lab Autom. 2015 Apr;20(2):107-26
pubmed: 25586998
Ann N Y Acad Sci. 2012 Jul;1258:43-51
pubmed: 22731714
Eur J Pharm Sci. 2004 Jan;21(1):77-86
pubmed: 14706814
Part Fibre Toxicol. 2012 May 31;9:18
pubmed: 22650444
Drug Discov Today. 2006 Oct;11(19-20):905-10
pubmed: 16997140
Pharm Res. 2008 Aug;25(8):1782-8
pubmed: 18058001
Curr Drug Metab. 2008 Nov;9(9):893-900
pubmed: 18991586
Biomaterials. 2016 Sep;101:321-40
pubmed: 27318094
Adv Drug Deliv Rev. 2006 Apr 20;58(1):15-28
pubmed: 16517003
Int J Pharm. 2010 Nov 15;400(1-2):183-93
pubmed: 20727955
PLoS One. 2015 Jul 20;10(7):e0133154
pubmed: 26192592
Eur J Pharm Sci. 2000 May;10(3):195-204
pubmed: 10767597
Cell Mol Life Sci. 2013 Feb;70(4):631-59
pubmed: 22782113

Auteurs

Nicholas G Lamson (NG)

Department of Chemical Engineering, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, Pennsylvania, 15213-3890, USA.

Rebecca L Ball (RL)

Department of Chemical Engineering, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, Pennsylvania, 15213-3890, USA.

Katherine C Fein (KC)

Department of Chemical Engineering, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, Pennsylvania, 15213-3890, USA.

Kathryn A Whitehead (KA)

Department of Chemical Engineering, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, Pennsylvania, 15213-3890, USA. kawhite@cmu.edu.
Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. kawhite@cmu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH